INTRODUCTION
The demonstration of an increased prevalence of selective IgA deficiency (SIgAD) in systemic lupus erythematosus (SLE) (1) and a report of an increased frequency of antibody to DNA in immune deficiency (2) prompted study of the frequency of antibodies to native and denatured DNA, to single-stranded RNA, and to other nuclear antigens in a large group of individuals with SIgAD.
MATERIALS AND METHODS

Study Groups
The individuals with SIgAD all had serum IgA levels co.01 mg/ml as determined by radial diffusion in gel (3). Of 21 symptomatic patients, 8 had juvenile rheumatoid arthritis or ankylosing spondylitis, 7 recurrent upper respiratory tract infections, 3 malabsorption syndromes, 1 thyroiditis, 1 dermatomyositis, and 1 Gaucher's disease. Sera from SIgAD blood donors were obtained from the Blood Transfusion Service of the Canadian Red Cross in Winnipeg. Non-IgA-deficient blood donors and patients with SLE but normal or elevated levels of IgA were included for comparison.
Preparation
of Radioiodinated Antigens Calf thymus DNA (Sigma) or transfer RNA (tRNA) were labeled with lz51 by the thallium trichloride method (4). Double-stranded 1251-labeled DNA (dsDNA) was then isolated by passage through a hydroxyl apatite column (5) . Only DNA preparations having ~2% cleavage by Sl nuclease were used (6) . Denatured DNA was prepared by heating the dsDNA to 100°C for 15 min and cooling it rapidly on ice. tRNA was isolated by thermal elution from hydroxyl apatite (7). Quantitation of Antibody Reactive with Nucleic Acid Antigens Anti-DNA antibodies were quantitated in triplicate by an ammonium sulfate precipitation technique previously described (8) . The results were expressed as percentage binding of 0.26 pg '25i-labeled DNA by 15 ~1 of serum. Anti-tRNA antibodies were measured in duplicate by an ammonium sulfate precipitation technique: 0.20 fig of lz51-labeled tRNA was incubated with 60 ~1 of serum for 1 hr at room temperature. The assay was otherwise performed as described for anti-DNA (8) . Antinuclear antibodies in undiluted serum were demonstrated by immunofluorescence (F-ANA) using mouse liver substrate as previously described (9) .
Antibodies to dsDNA
RESULTS
The values for percentage binding in the control and SIgAD groups are shown in Fig. 1 . Binding in the control group (n = 83) was 1.96 +-0.95% (mean -e 1 SD), range 0.52 to 5.4%. In patients with SLE, but with normal or increased levels of IgA (n = 36), binding ranged from 2.1 to 64.3% (15.9 r 15.5). In the group with SIgAD as a whole (R = 121), the range of binding was 0.17 to 11.6%. Of the symptomatic patients with SIgAD, one had anti-dsDNA levels beyond 2 SD of the normal mean. Of 100 blood donors with SIgAD, 4 had elevation of DNA binding beyond 2 SD of the normal mean. Second samples, obtained 3 to 6 months after the initial samples, and medical histories were obtained from each of these donors. F-ANA, such antibodies were demonstrated in second samples from 2 donors with the highest binding to dsDNA.
Antibodies to Denatured DNA The mean percentage binding of denatured DNA in SIgAD donors (5.99 k 3.76%, n = 89) was lower than that in normal donors (9.66 t 3. I%, n = 90) (Fig.  2) . Elevated leveis were found in 12 patients with SLE and in one IgA-deficient donor who also had elevated antibody to dsDNA.
Antibodies to tRNA
Values in the control group (n = 83) showed tRNA binding of from 1.62 to 6.76% (3.7 & 2.45). In non-IgA-deficient patients with SLE (n = 23), binding ranged from 1.43 to 13.74% (7.17 + 2.50). In the asymptomatic IgA-deficient blood donors fn = 65) values ranged from 0. I6 to 11.65% (4.62 t 1.98).
Antinuclear Antibodies F-ANA were detected in 3 of 100 IgA-deficient blood donors and in none of the 83 normal blood donors.
DISCUSSION
The overall frequency of F-ANA and elevated levels of binding to native or denatured DNA or to transfer RNA were not significantly different in IgAdeficient and non-IgA-deficient blood donor populations. However, four IgAdeficient donors were found to have persistently increased levels of antibody to dsDNA (>2 SD normal mean), although there was no evidence of autoimmune disease. Further follow-up will be necessary in order to evaluate the possibility that these donors are developing SLE. We conclude from these data that there is no intrinsic association between SIgAD and increased levels of antibody to nuclear antigens, and that any apparent association is attributable to an underlying autoimmune disease (SLE) rather than to SIgAD per se. This conclusion contrasts with that of Gershwin et al. (2) who noted an association between SIgAD and antibodies to nucleic acids. Of 37 IgAdeficient patients whom they reported, 6 had antibodies to dsDNA, 7 to ssDNA, and 4 to dsRNA. Of the 1 I patients who had antibodies to at least one nucleic acid antigen, 5 were asymptomatic, 2 had rheumatoid arthritis, and 1 each had Hodgkin's disease, juvenile rheumatoid arthritis, recurrent infections, and antibody to Factor XI. No patient was thought to have SLE. Their study and ours differ with respect to criteria for designation of SIgAD, techniques used to assay antibodies, and patient and donor origins. Such differences may contribute to the apparent disparity between the reported results and conclusions.
